Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 30, 2023. (Total: 221577Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 10 (of 10 Records)

Query Trace: Melanoma and IDH1[original query]
IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain.
Biochemical and biophysical research communications 2010 Jul 398 (3): 585-7.
Lopez Giselle Y, Reitman Zachary J, Solomon David, Waldman Todd, Bigner Darell D, McLendon Roger E, Rosenberg Steven A, Samuels Yardena, Yan H
Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation.
The American journal of pathology 2011 Mar 178 (3): 1395-402.
Shibata Tatsuhiro, Kokubu Akiko, Miyamoto Masashi, Sasajima Yuko, Yamazaki Nao
HMGA2 expression pattern and TERT mutations in tumors of the vulva.
Oncology reports 2015 Jun 33 (6): 2675-80.
Agostini Antonio, Panagopoulos Ioannis, Andersen Hege Kilen, Johannesen Lene Elisabeth, Davidson Ben, Tropé Claes Göran, Heim Sverre, Micci Frances
High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.
Melanoma research 2015 Mar .
van den Hurk Karin, Balint Balazs, Toomey Sinead, O'Leary Patrick C, Unwin Louise, Sheahan Kieran, McDermott Enda W, Murphy Ian, van den Oord Joost J, Rafferty Mairin, FitzGerald Dara M, Moran Julie, Cummins Robert, MacEneaney Owen, Kay Elaine W, O'Brien Cathal P, Finn Stephen P, Heffron Cynthia C B B, Murphy Michelle, Yela Ruben, Power Derek G, Regan Padraic J, McDermott Clodagh M, O'Keeffe Allan, Orosz Zsolt, Donnellan Paul P, Crown John P, Hennessy Bryan T, Gallagher William
Role of rare germline copy number variation in melanoma-prone patients.
Future oncology (London, England) 2016 Mar .
Fidalgo Felipe, Rodrigues Tatiane Cristina, Silva Amanda Gonçalves, Moredo Facure Luciana, de Sá Bianca Costa Soares, Duprat João Pedreira, Achatz Maria Isabel, Rosenberg Carla, Carraro Dirce Maria, Krepischi Ana Cristina Victori
TET2 binds the androgen receptor and loss is associated with prostate cancer.
Oncogene 2016 Nov .
Nickerson M L, Das S, Im K M, Turan S, Berndt S I, Li H, Lou H, Brodie S A, Billaud J N, Zhang T, Bouk A J, Butcher D, Wang Z, Sun L, Misner K, Tan W, Esnakula A, Esposito D, Huang W Y, Hoover R N, Tucker M A, Keller J R, Boland J, Brown K, Anderson S K, Moore L E, Isaacs W B, Chanock S J, Yeager M, Dean M, Andresson
Isocitrate dehydrogenase 1 mutations in melanoma frequently co-occur with NRAS mutations.
Histopathology 2018 7 73 (6): 963-968.
Linos Konstantinos, Tafe Laura
Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy.
Targeted oncology 2020 1 15 (1): 101-113.
Olbryt Magdalena, Pig?owski Wojciech, Rajczykowski Marcin, Pfeifer Aleksandra, Student Sebastian, Fiszer-Kierzkowska An
Definition of Biologically Distinct Groups of Conjunctival Melanomas According to Etiological Factors and Implications for Precision Medicine.
Cancers 2021 8 13 (15): .
Gardrat Sophie, Houy Alexandre, Brooks Kelly, Cassoux Nathalie, Barnhill Raymond, Dayot Stéphane, Bièche Ivan, Raynal Virginie, Baulande Sylvain, Marais Richard, Roman-Roman Sergio, Stern Marc-Henri, Rodrigues Manu
NGS-Based Analysis of Atypical Deep Penetrating Nevi.
Cancers 2021 7 13 (12): .
Manca Antonella, Sini Maria Cristina, Cesinaro Anna Maria, Portelli Francesca, Urso Carmelo, Lentini Maria, Cardia Roberta, Alos Llucia, Cook Martin, Simi Sara, Paliogiannis Panagiotis, De Giorgi Vincenzo, Cossu Antonio, Palmieri Giuseppe, Massi Danie
TOP